Jaffe C J, Vierling J M, Jones E A, Lawley T J, Frank M M
J Clin Invest. 1978 Nov;62(5):1069-77. doi: 10.1172/JCI109212.
An approach to the assessment of reticuloendothelial function that quantitates clearance specifically mediated by membrane receptors for C3b and immunoglobulin (Ig)G has been applied in man. Clearance of isologous erythrocytes coated with IgM or C3b or coated with IgG were examined in patients with primary biliary cirrhosis (PBC), chronic hepatitis, or alcoholic cirrhosis and normal control subjects and compared with the clearance of aggregated human serum albumin. Clearance of these three types of particles varied independently. None of the patients studied had a defect in the clearance of aggregated albumin. No patient with PBC (0:6) had delayed clearance of IgG-coated erythrocytes; one of six patients with chronic hepatitis had delayed clearance of these cells. Indeed, four of six with PBC had increased rates of IgG-mediated clearance. In contrast, six out of six patients with PBC had an unequivocal defect in clearance mediated by C3b receptors. The patients with PBC varied widely in terms of duration of symptoms, degree of cholestasis, and histologic stage of disease. No defect of C3b-mediated erythrocyte clearance was found in the patients with chronic hepatitis or alcoholic cirrhosis. Furthermore, a patient with severe cholestasis secondary to large duct biliary obstruction exhibited normal C3b-mediated clearance. The defect in C3b-mediated clearance in PBC did not correlate with serum levels of individual complement components or inhibitors or with the presence of circulating immune complexes as measured by the Clq precipitation assay. Thus, measurements of receptor specific clearance, but not clearance of aggregated proteins, have revealed a highly specific defect in reticuloendothelial function in PBC.
一种评估网状内皮系统功能的方法已应用于人体,该方法可定量由C3b和免疫球蛋白(Ig)G的膜受体特异性介导的清除作用。在原发性胆汁性肝硬化(PBC)、慢性肝炎或酒精性肝硬化患者以及正常对照受试者中,检测了包被IgM或C3b或包被IgG的同种红细胞的清除情况,并与聚合人血清白蛋白的清除情况进行比较。这三种类型颗粒的清除情况各自独立变化。所研究的患者中没有一个在聚合白蛋白清除方面存在缺陷。没有PBC患者(0:6)存在IgG包被红细胞清除延迟的情况;6例慢性肝炎患者中有1例存在这些细胞清除延迟的情况。实际上,6例PBC患者中有4例IgG介导的清除率增加。相比之下,6例PBC患者中有6例在由C3b受体介导的清除方面存在明确缺陷。PBC患者在症状持续时间、胆汁淤积程度和疾病组织学分期方面差异很大。慢性肝炎或酒精性肝硬化患者未发现C3b介导的红细胞清除缺陷。此外,一名因大胆管胆管阻塞继发严重胆汁淤积的患者表现出正常的C3b介导的清除。PBC中C3b介导的清除缺陷与单个补体成分或抑制剂的血清水平或与通过Clq沉淀试验测量的循环免疫复合物的存在无关。因此,受体特异性清除的测量,而非聚合蛋白的清除测量,揭示了PBC中网状内皮系统功能的高度特异性缺陷。